The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analysis
PubMed 38928470 · doi:10.3390/ijms25126765
What was done
This is a narrative review summarizing the biochemical mechanisms of the ubiquinone-ubiquinol redox cycle across mitochondrial complexes (Complex I, II, and III) and extra-mitochondrial oxidoreductases. It evaluates the clinical consequences of deficiencies within this pathway and discusses the therapeutic potential of CoQ10 and selenium co-supplementation.
What was found
The abstract reports no quantitative data or specific numerical outcome measures. It describes the structural requirements of the redox cycle and identifies CoQ10 and selenium co-supplementation as having potential clinical benefits in deficiency states.
Why it matters
Clarifying the continuous interconversion between ubiquinone and ubiquinol provides a mechanistic basis for how disruptions in the redox cycle affect cellular metabolism and informs rational nutritional supplementation strategies.
Limits
This is a qualitative review with no systematic search criteria, meta-analytic pooling, or direct experimental data presented in the abstract. No sample sizes, effect sizes, or risk estimates are reported.
Cited by
- supports Ubiquinol is the reduced form of CoQ10, while ubiquinone is the oxidized form.